Skip to content
CancerIndex

Publication

Acute myeloid leukemia: 2012 update on diagnosis, risk stratification, and management.

Authors not recorded

Am J Hematol2012PMID 22180162stubpubmedProvenance
Source
PubMed
Retrieved
Sep 8, 2026
Layer
normalized (units and labels harmonized; values unchanged)
Run
ING-CIVIC-20260908-000001
Published

Abstract

Abstract (excerpt)

Only the opening of the abstract is shown; abstract text may carry publisher copyright.

Data not yet available

No abstract stored. Read on PubMed

Linked entities

Linked entities (3)

How each link was made (MeSH, dictionary, registry reference, curation…) and whether it has been validated. Candidate links are not counted in entity statistics.

Validated 3

Curated evidence

Evidence citing this paper (2)

civicProvenance
Source
CIViC — Clinical Interpretation of Variants in Cancer
Dataset
CIViC evidence items
Version
civic-2026-09-08
Retrieved
Sep 8, 2026
Layer
normalized (units and labels harmonized; values unchanged)
Evidence
expert curation
License
CC0 1.0
PMID
22180162
Run
ING-CIVIC-20260908-000001
Open at source
CuratedShowing 1–2 of 2 evidence items · levels, directions and significance as curated at the source; each row links to its CIViC record.
TherapyCancerTypeLevelDirection · significanceRating (1–5)StatusEvidenceSource
MYH11 Fusion2
(prognostic)Acute Myeloid LeukemiaCURATED_BROADERPrognosticBSupports Better Outcome4rejected
EID1026

The CBFB-MYH11 fusion has been shown to be associated with favorable prognosis in patients with acute myeloid leukemia.

PMID 22180162 · Estey, 2012 · Open in CIViC

civic
〃Acute Myeloid LeukemiaCURATED_BROADERPrognosticBSupports Better Outcome4accepted
EID1027

The CBFB-MYH11 fusion has been shown to be associated with favorable prognosis in acute myeloid leukemia.

PMID 22180162 · Estey, 2012 · Open in CIViC

civic